SCHEMBL1103445

SCHEMBL1103445

c1ccc(-c2c3ccccc3c(N3c4ccccc4Oc4ccccc43)c3cnc4ccccc4c23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.37
CCND1 P24385 1/20 0.37
TLR7 Q9NYK1 4/20 0.34
ALDH1A1 P00352 5/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 3/20 0.34
POLB P06746 2/20 0.34
LMNA P02545 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NPSR1 Q6W5P4 3/20 0.33
ADORA2A P29274 1/20 0.33
HTT P42858 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103313 0.87 CDK4 (0.36) CDK4CCND1TLR7ALDH1A1MAPT
SCHEMBL1103552 0.87 MET (0.36) CDK4CCND1MAPTCYP1A2KDM4E
SCHEMBL1103442 0.84 TLR7 (0.35) CDK4CCND1TLR7ALDH1A1MAPT
SCHEMBL1103612 0.84 POLB (0.35) CDK4CCND1ALDH1A1MAPTPOLB
SCHEMBL1103432 0.83 TLR7 (0.36) CDK4CCND1TLR7ALDH1A1MAPT
SCHEMBL1103441 0.83 TLR7 (0.34) CDK4CCND1TLR7ALDH1A1MAPT
SCHEMBL1103443 0.82 TLR7 (0.36) CDK4CCND1TLR7ALDH1A1MAPT
SCHEMBL1103348 0.78 CDK4 (0.34) CDK4CCND1
SCHEMBL1103072 0.76 HTT (0.33) CDK4CCND1ALDH1A1MAPTHPGD
SCHEMBL1102891 0.76 ALOX5 (0.36) CDK4CCND1ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 CDK4 1577/4885CCND1 22/4885TLR7 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.